Stanford's Center for Internet and Society has long received funding from Google, but a filing shows the university recently pledged to only use the money for non-privacy research. Academics say such promises are problematic.
Some insurers are starting to charge patients more out of pocket for generic drugs, including those that treat chronic illnesses like epilepsy and diabetes. Increased co-payments can limit options for such patients. Charles Ornstein discusses what consumers can do to avoid higher prices.
By charging higher prices for generic drugs that treat certain illness, health insurers may be violating the spirit of the Affordable Care Act, which bans discrimination against those with pre-existing conditions.